Michael D. Clayman, MD
Advertisement
Michael D. Clayman, MD, is chief executive officer and co-founder, Flexion Therapeutics.
Articles by Michael D. Clayman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
RAINIER: Povetacicept Cuts Proteinuria, Gd-IgA1 in IgA Nephropathy
2
Retatrutide Lowers Albuminuria, Glomerular Pressure in Obesity and CKD
3
Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD
4
IMAgINATION: Sefaxersen Meets Phase 3 Proteinuria Endpoint in IgA Nephropathy
5